zonisamide has been researched along with Cognitive Decline in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quon, RJ | 1 |
| Mazanec, MT | 1 |
| Schmidt, SS | 1 |
| Andrew, AS | 1 |
| Roth, RM | 1 |
| MacKenzie, TA | 1 |
| Sajatovic, M | 1 |
| Spruill, T | 1 |
| Jobst, BC | 1 |
1 other study available for zonisamide and Cognitive Decline
| Article | Year |
|---|---|
Antiepileptic drug effects on subjective and objective cognition.
Topics: Adult; Anticonvulsants; Cognition; Cognitive Dysfunction; Diagnostic Self Evaluation; Epilepsy; Fema | 2020 |